Evidence map›Paper›PMID 28657594›Full record

ReviewPathogens (Basel, Switzerland)2017

The Cytological Events and Molecular Control of Life Cycle Development of Trypanosoma brucei in the Mammalian Bloodstream.

Eleanor Silvester, Kirsty R McWilliam, Keith R Matthews

Abstract readReview
In one paragraph

Review in Pathogens (Basel, Switzerland), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed.

  1. Review
  2. Pathogens (Basel, Switzerland) · 2026
    Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Detection ofVeterinary world · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Steroidal Antimetabolites Protect Mice againstMolecules (Basel, Switzerland) · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Eleanor SilvesterInstitute for Immunology and Infection Research, Centre for Immunity, Infection and Evolution, School of Biological Sciences, King's Buildings, University of Edinburgh, Charlotte Auerbach Road, Edinburgh EH9 3FL, UK. Eleanor.Silvester@ed.ac.uk.
Kirsty R McWilliamInstitute for Immunology and Infection Research, Centre for Immunity, Infection and Evolution, School of Biological Sciences, King's Buildings, University of Edinburgh, Charlotte Auerbach Road, Edinburgh EH9 3FL, UK. K.R.McWilliam@sms.ed.ac.uk.
Keith R MatthewsInstitute for Immunology and Infection Research, Centre for Immunity, Infection and Evolution, School of Biological Sciences, King's Buildings, University of Edinburgh, Charlotte Auerbach Road, Edinburgh EH9 3FL, UK. keith.matthews@ed.ac.uk.

Funding

Wellcome Trust
6 · The paper itself

Abstract

African trypanosomes cause devastating disease in sub-Saharan Africa in humans and livestock. The parasite lives extracellularly within the bloodstream of mammalian hosts and is transmitted by blood-feeding tsetse flies. In the blood, trypanosomes exhibit two developmental forms: the slender form and the stumpy form. The slender form proliferates in the bloodstream, establishes the parasite numbers and avoids host immunity through antigenic variation. The stumpy form, in contrast, is non-proliferative and is adapted for transmission. Here, we overview the features of slender and stumpy form parasites in terms of their cytological and molecular characteristics and discuss how these contribute to their distinct biological functions. Thereafter, we describe the technical developments that have enabled recent discoveries that uncover how the slender to stumpy transition is enacted in molecular terms. Finally, we highlight new understanding of how control of the balance between slender and stumpy form parasites interfaces with other components of the infection dynamic of trypanosomes in their mammalian hosts. This interplay between the host environment and the parasite's developmental biology may expose new vulnerabilities to therapeutic attack or reveal where drug control may be thwarted by the biological complexity of the parasite's lifestyle.

Indexed as

differentiationlife-cyclequorum sensingstumpy formtransmissionTrypanosoma brucei

Identifiers

PMID28657594
PMCPMC5617986

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.